Effective Combination of CPX-351 with FLT3 Inhibitors in AML Blasts Harboring the FLT3-ITD Mutation

被引：3
|
作者：
Edwards, David K. [1 ]
Javidi-Sharifi, Nathalie [1 ]
Rofelty, Angela [2 ]
Rosenfeld, Claire [3 ]
Roth-Carter, Riley [3 ]
Tardi, Paul [4 ]
Mayer, Lawrence [4 ]
Tyner, Jeffrey W. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA
[4] Jazz Pharmaceut, Vancouver, BC, Canada
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5124.5124
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5124
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Combination of c-SRC and FLT3 Inhibitors Has An Additive Inhibitory Effect on FLT3 ITD but Not on FLT3 TKD Positive Cells
    Leischner, Hannes
    Grundler, Rebekka
    Albers, Corinna
    Illert, Anna Lena
    Goetze, Katharina
    Peschel, Christian
    Duyster, Justus
    BLOOD, 2010, 116 (21) : 1191 - 1191
  • [42] CPX-351 in FLT3-mutated acute myeloid leukemia
    Andrews, Claire
    Pullarkat, Vinod
    Recher, Christian
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] FLT3-ITD Mutation in MDS Patients Is Associated with Early Transformation to AML
    Sumiyoshi, Ritsu
    Tashiro, Haruko
    Matsuo, Takuji
    Yamamoto, Tadashi
    Oka-Miura, Yoko
    Matsumoto, Kensuke
    Ooi, Jun
    Shirafuji, Naoki
    BLOOD, 2017, 130
  • [44] Use of FLT3 Inhibitors in AML
    Smith, Catherine C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S92 - S94
  • [45] Bone marrow stroma-mediated resistance to FLT3 inhibitors in FLT3-ITD AML is mediated by persistent activation of extracellular regulated kinase
    Yang, Xiaochuan
    Sexauer, Amy
    Levis, Mark
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (01) : 61 - 72
  • [46] Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD
    Takahashi, Koichi
    Kantarjian, Hagop
    Pemmaraju, Naveen
    Andreeff, Michael
    Borthakur, Gautam
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Pierce, Sherry
    Luthra, Rajyalakshmi
    Cardenas-Turanzas, Marylou
    Estrov, Zeev
    Ravandi, Farhad
    Cortes, Jorge
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (05) : 659 - 666
  • [47] Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML
    H Wu
    C Hu
    A Wang
    E L Weisberg
    W Wang
    C Chen
    Z Zhao
    K Yu
    J Liu
    J Wu
    A Nonami
    L Wang
    B Wang
    R M Stone
    S Liu
    J D Griffin
    J Liu
    Q Liu
    Leukemia, 2016, 30 : 754 - 757
  • [48] Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML
    Wu, H.
    Hu, C.
    Wang, A.
    Weisberg, E. L.
    Wang, W.
    Chen, C.
    Zhao, Z.
    Yu, K.
    Liu, J.
    Wu, J.
    Nonami, A.
    Wang, L.
    Wang, B.
    Stone, R. M.
    Liu, S.
    Griffin, J. D.
    Liu, J.
    Liu, Q.
    LEUKEMIA, 2016, 30 (03) : 754 - 757
  • [49] Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
    Green, Alexa S.
    Maciel, Thiago T.
    Hospital, Marie-Anne
    Yin, Chae
    Mazed, Fetta
    Townsend, Elizabeth C.
    Pilorge, Sylvain
    Lambert, Mireille
    Paubelle, Etienne
    Jacquel, Arnaud
    Zylbersztejn, Florence
    Decroocq, Justine
    Poulain, Laury
    Sujobert, Pierre
    Jacque, Nathalie
    Adam, Kevin
    So, Jason C. C.
    Kosmider, Olivier
    Auberger, Patrick
    Hermine, Olivier
    Weinstock, David M.
    Lacombe, Catherine
    Mayeux, Patrick
    Vanasse, Gary J.
    Leung, Anskar Y.
    Moura, Ivan C.
    Bouscary, Didier
    Tamburini, Jerome
    SCIENCE ADVANCES, 2015, 1 (08):
  • [50] FLT3 INHIBITORS DRIVE CLONAL TRILINEAGE TERMINAL DIFFERENTIATION OF NPM1-MUTATED/FLT3-ITD AML MIMICKING HEMATOLOGICAL RESPONSE
    Martelli, M. P.
    Ciurnelli, R.
    Cardinali, V.
    Pierangeli, S.
    Cecchini, D.
    Bigerna, B.
    Gionfriddo, I.
    Papayannidis, C.
    Martinelli, G.
    Ascani, S.
    Falzetti, F.
    Falini, B.
    HAEMATOLOGICA, 2018, 103 : S19 - S19
12345